Home › NDC Lookup › RxCUI directory › RxCUI 2569836

Dihydroergotamine mesylate 0.725 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 2569836

RxNorm drug concept · Semantic clinical drug
RxCUI 2569836 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2569836
Official nameDihydroergotamine mesylate 0.725 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDHE mesylate 0.725 MG/ACTUAT Metered Dose Nasal Spray
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dihydroergotamine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It works by activating certain serotonin receptors in the brain, which helps shrink swollen blood vessels and block pain signals from your trigeminal nerve — the nerve network resp...
  • What exactly does this injection do for my migraine?
  • Brekiya is injected just under the skin of your middle thigh. Remove the red needle cap, press the device firmly against a clean area of skin, then push and release the gray activa...
  • How do I use the Brekiya autoinjector at home?
📖 Read our full Dihydroergotamine Injection guide →

🕸️ Concept Web — How Dihydroergotamine mesylate 0.725 MG/ACTUAT Meter... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dihydroergotamine mesylate 0.725 MG/ACTUAT Metered Dose Nasal Spray RxCUI 2569836

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dihydroergotamine 3418
    • Dihydroergotamine mesylate 203176
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Trudhesa 2569837
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dihydroergotamine Metered Dose Nasal Spray 2201618
    • Dihydroergotamine mesylate Metered Dose Nasal Spray 2648053
    • Dihydroergotamine Inhalant Product 1151867
    • Dihydroergotamine Nasal Product 1151869
    • Dihydroergotamine mesylate Inhalant Product 2661762
    • Dihydroergotamine mesylate Nasal Product 2663124
    • Dihydroergotamine Metered Dose Nasal Spray [Trudhesa] 2569841
    • Dihydroergotamine mesylate Metered Dose Nasal Spray [Trudhesa] 2658259
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dihydroergotamine mesylate 0.725 MG/ACTUAT SCDC · 2569835
  • Dihydroergotamine Metered Dose Nasal Spray SCDF · 2201618
  • Dihydroergotamine mesylate Metered Dose Nasal Spray SCDFP · 2648053
  • Dihydroergotamine Inhalant Product SCDG · 1151867
  • Dihydroergotamine Nasal Product SCDG · 1151869
  • Dihydroergotamine mesylate Inhalant Product SCDGP · 2661762
  • Dihydroergotamine mesylate Nasal Product SCDGP · 2663124

Brand-Name Concepts

  • Dihydroergotamine mesylate 0.725 MG/ACTUAT Metered Dose Nasal Spray [Trudhesa] SBD · 2569842
  • Dihydroergotamine mesylate 0.725 MG/ACTUAT [Trudhesa] SBDC · 2569838
  • Dihydroergotamine Metered Dose Nasal Spray [Trudhesa] SBDF · 2569841
  • Dihydroergotamine mesylate Metered Dose Nasal Spray [Trudhesa] SBDFP · 2658259
  • Trudhesa Inhalant Product SBDG · 2569839
  • Trudhesa Nasal Product SBDG · 2569840
  • Trudhesa BN · 2569837

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2569836 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
77530-0725-00 1 VIAL, GLASS in 1 CARTON (77530-725-00) / 1 mL in 1 VIAL,... Trudhesa Impel Pharmaceuticals LLC 2021-09-24
77530-0725-04 4 VIAL, GLASS in 1 CARTON (77530-725-04) / 1 mL in 1 VIAL,... Trudhesa Impel Pharmaceuticals LLC 2021-09-24
Observed labelers: Impel Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.